Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring

The 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery.

Subsidie
€ 2.500.000
2022

Projectdetails

Introduction

Cardiovascular diseases are the leading cause of death globally. Monitoring heart functions and ischemia is critical for survival after cardiac surgery. Standard monitoring methods such as echocardiogram and ELISA blood tests provide single-time measurements.

Limitations of Current Methods

These methods are available only in hospitals, and there is no continuous monitoring method after patients are discharged. This leads to a high rate of recurrent heart failures and rehospitalization.

Challenges with Implantable Devices

Implantable medical devices are used for the treatment of various disorders. However, their non-resorbable nature necessitates an implant removal surgery that puts additional risk of infection and stress on patients. This limitation restricts their use in postoperative monitoring.

The Promise of Bioresorbable Implants

Bioresorbable implants may soon revolutionize postoperative monitoring methods. The surgeon will implant a small patch onto the heart during surgery, enabling continuous cardiac monitoring and early alerts for heart failure.

Benefits of Bioresorbable Implants

This approach will:

  • Reduce sudden attacks
  • Decrease rehospitalizations
  • Lower the financial burden of healthcare

Once the monitoring period ends, triggering with a light source will dissolve the implant, providing a significant second chance for survivors of cardiac failure without the burden of secondary surgery.

Current Technological Limitations

The technological advancements to bring this vision to the clinic are not available yet.

Project Overview: 2ND-CHANCE

2ND-CHANCE will facilitate this vision by building components of next-generation wireless implants with triggered bioresorption for cardiac surgery through ground-breaking approaches.

Project Goals

This interdisciplinary project aims to develop:

  1. Bioresorbable sensors compatible with the in-body environment
  2. Battery-free ultrasonic communication
  3. Encapsulation layer with triggered bioresorption
  4. Integration and animal tests

Broader Implications

The versatility of the 2ND-CHANCE project will also yield potential breakthroughs in fields where monitoring of tissues and biomarkers is crucial, such as neurology and ophthalmology, and will open new research perspectives.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.500.000
Totale projectbegroting€ 2.500.000

Tijdlijn

Startdatum1-6-2022
Einddatum31-5-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • KOC UNIVERSITYpenvoerder

Land(en)

Türkiye

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Deep-Body Wireless Bioelectronics Enabled by Physics-Based Bioadaptive Wave Control

The project aims to develop bio-adaptive wave control technologies for efficient powering and precise control of wireless bioelectronic implants in the body, enhancing medical monitoring and therapy delivery.

€ 1.499.973
ERC Starting...

Neuromorphic Flexible Electro/chemical Interface for in-Memory Bio-Sensing and Computing.

Develop a miniaturized, self-contained biosensing technology using neuromorphic devices for real-time monitoring and classification of neurodegenerative biomarkers in individualized healthcare.

€ 1.500.000
ERC Advanced...

Unique non-invasive pace-mapping system to identify subjects at risk of arrhythmic sudden death

Develop a non-invasive mapping and pacing system to detect cardiac signals for predicting sudden cardiac death, improving early diagnosis and management of heart disease.

€ 2.488.400
ERC Starting...

Biodegradable MEMS implants for nerve repair

Develop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury.

€ 1.672.968
ERC Proof of...

Multianalyte Continuum Nanopores Sensing

MC-Nano aims to develop a real-time nanopore sensing tool for continuous monitoring of heart failure biomarkers in urine, enhancing diagnostic accuracy and personalizing patient treatment.

€ 150.000

Vergelijkbare projecten uit andere regelingen

EIC Transition

Novel microsensing platform for remote patient monitoring

The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.

€ 2.499.051
Mkb-innovati...

Draadloze pacemaker en slimme monitoring

Dit project ontwikkelt een draadloze pacemaker met slimme monitoring om patiënten beter te behandelen en zorgkosten te verlagen.

€ 20.000
EIC Pathfinder

In-vessel implantable smart sensing device for personalised medicine

The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.

€ 4.158.610
EIC Accelerator

Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis

VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.

€ 2.500.000
EIC Pathfinder

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

€ 2.606.250